Johnson & Johnson Aware of High Failure Rates Two Years Before DePuy ASR Hip Recall
Two years before the DePuy ASR hip recall, Johnson & Johnson executives learned about the dangers of the hip implant, according to documents revealed in a California state court.
In 2008, the company received data that showed “extreme” levels of toxic metal ions in patients with a DePuy ASR hip implant. The friction from the metal-on-metal ball and socket joint of the ASR hip replacement caused metal debris to shed into the surrounding bloodstream, and can cause serious adverse effects in patients.
According to his testimony during a deposition in the California litigation, the DePuy official told colleagues at the company “I believe it means that we need to start any ASR upgrade sooner than our previous plans had suggested.”
An internal J&J analysis in 2011 showed that nearly 36 percent of the ASR hip implants were expected to fail within five years. But it wasn’t until August 2010 that the DePuy ASR hip recall was finally issued, affecting 93,000 devices worldwide.
DePuy ASR Hip Lawsuits Continue Over Hip Replacement Failure
J&J began to phase out production of the metal hip replacement in 2009, and recalled the devices after data from the National Joint Registry of England and Wales revealed that the ASR hip implants had a 12 to 13 percent failure rate. The generally accepted failure rate for hip replacement implants is no more than 5 percent.
Thousands of patients who received DePuy ASR hip implants suffered from serious complications, including pain, infection, tissue damage, and metallosis, ultimately forcing them to undergo revision surgery to remove the dangerous hip implant.
The company is currently facing over 10,000 DePuy ASR hip recall lawsuits filed by victims of the recall. The ASR hip replacement lawsuits allege that J&J designed a defective product, and marketed the hip implant without adequately warning patients about the risks associated with them. In fact, the evidence uncovered in the California litigation suggests that J&J continued to market the devices even after evidence of high failure rates.
According to a J&J spokeswoman, the company “acted in the best interest of patients” in issuing the voluntary DePuy ASR hip recall.
Over 7,000 DePuy ASR hip lawsuits are currently gathered before Judge David A. Katz in the U.S. District Court for the Northern District of Ohio, and some 2,000 lawsuits are underway in California state court. Tens of thousands of pages of documents have been produced in the discovery process, with over 50 witnesses deposed. J&J has recently stated that it has spent about $900 million on DePuy ASR hip recall costs.
Filing A DePuy ASR Hip Recall Lawsuit
If you experienced complications or had revision surgery as a result of a DePuy ASR hip implant, you may be entitled to compensation for your medical costs, lost income, pain and suffering, and more through filing a DePuy ASR hip recall lawsuit. Speak to a DePuy hip replacement lawyer at our firm today to learn more. Call 1-877-779-1414.